Skip to main content
  • Donate Blood (Opens in a new tab/window)
  • About NBA
  • News and updates
  • Resources
  • BloodPortal login (Opens in a new tab/window)
Logo image Logo image
  • Blood Products
    • Blood Products
    • National Product Price List
    • Fresh Blood Products
    • Albumin Products
    • Clotting Factor and Other Products
    • Immunoglobulin Products
      • Immunoglobulin Usage and Data
      • Intravenous Immunoglobulin (IVIg)
      • Subcutaneous Immunoglobulin (SCIg)
      • Normal Human Immunoglobulin (NHIg)
      • Hyperimmune Immunoglobulin Products
    • Access and Ordering
      • BloodSTAR for Ig Products
      • BloodSTAR Registration Form
      • BloodNet for Blood Products from Lifeblood
      • BloodNet System Interface
      • Frequently Asked Questions
    • Blood Product Management
      • Inventory Management
      • Blood Product Wastage
      • Blood and Inventory Management Resources
      • Case Studies
      • Single Unit Transfusion Guide
  • Supply System
    • Supply System
    • Managing Blood Supply
      • Risk Management
      • National Stewardship Program
      • Blood Product Labelling
    • Governance for Immunoglobulin Products
      • National Immunoglobulin Governance Committees
      • Criteria for Immunoglobulin Products
    • Suppliers and Commercial Supply Contracts
      • Fresh Blood Product Supply and Lifeblood
      • Plasma and Recombinant Product Supply
      • Imported Product Supply
      • Red Cell Diagnostic Product Supply
    • Australian Health Provider Access to Blood and Blood Products
    • Overseas Supply of Blood Products
  • Clinical Guidance
    • Clinical Guidance
      • Rh D Ig Guideline (Opens in a new tab/window)
      • PBM Guidelines (Opens in a new tab/window)
    • National Standards
    • Immunoglobulin
    • Patient Blood Management
      • Patient Blood Management (PBM) Resources
    • Transfusion-related Adverse Events
    • Bleeding Disorders
      • Australian Bleeding Disorders Registry (ABDR)
    • eLearning Courses
    • Public Consultations
    • Patient Blood Management Guidelines (Opens in a new tab/window)
  • Data and Research
    • Data and Research
    • Data and Reporting
    • Research Funding Program
      • Successful Grant Rounds
  • Patient Information
    • Patient information
    • Bleeding disorders
    • Blood disorders
    • Travelling with blood products
    • MyABDR app and the ABDR

Search

  • Donate Blood (Opens in a new tab/window)
  • About NBA
  • News and updates
  • Resources
  • BloodPortal login (Opens in a new tab/window)
  • Blood Products
    • Blood Products
    • National Product Price List
    • Fresh Blood Products
    • Albumin Products
    • Clotting Factor and Other Products
    • Immunoglobulin Products
      • Immunoglobulin Usage and Data
      • Intravenous Immunoglobulin (IVIg)
      • Subcutaneous Immunoglobulin (SCIg)
      • Normal Human Immunoglobulin (NHIg)
      • Hyperimmune Immunoglobulin Products
    • Access and Ordering
      • BloodSTAR for Ig Products
      • BloodSTAR Registration Form
      • BloodNet for Blood Products from Lifeblood
      • BloodNet System Interface
      • Frequently Asked Questions
    • Blood Product Management
      • Inventory Management
      • Blood Product Wastage
      • Blood and Inventory Management Resources
      • Case Studies
      • Single Unit Transfusion Guide
  • Supply System
    • Supply System
    • Managing Blood Supply
      • Risk Management
      • National Stewardship Program
      • Blood Product Labelling
    • Governance for Immunoglobulin Products
      • National Immunoglobulin Governance Committees
      • Criteria for Immunoglobulin Products
    • Suppliers and Commercial Supply Contracts
      • Fresh Blood Product Supply and Lifeblood
      • Plasma and Recombinant Product Supply
      • Imported Product Supply
      • Red Cell Diagnostic Product Supply
    • Australian Health Provider Access to Blood and Blood Products
    • Overseas Supply of Blood Products
  • Clinical Guidance
    • Clinical Guidance
      • Rh D Ig Guideline
      • PBM Guidelines
    • National Standards
    • Immunoglobulin
    • Patient Blood Management
      • Patient Blood Management (PBM) Resources
    • Transfusion-related Adverse Events
    • Bleeding Disorders
      • Australian Bleeding Disorders Registry (ABDR)
    • eLearning Courses
    • Public Consultations
    • Patient Blood Management Guidelines
  • Data and Research
    • Data and Research
    • Data and Reporting
    • Research Funding Program
      • Successful Grant Rounds
  • Patient Information
    • Patient information
    • Bleeding disorders
    • Blood disorders
    • Travelling with blood products
    • MyABDR app and the ABDR

Red cell diagnostic product supply

  • Home
  • Suppliers and commercial supply contracts
  • Red cell diagnostic product supply

Red cell diagnostic products (RCDP) are used for testing to:

  • identify the blood group of human red blood cells
  • detect red blood cell antibodies
  • control, standardise and validate routine haematology tests.

RCDP are used in laboratory tests for blood typing and cross-matching. These tests make sure blood transfusion patients receive blood that matches their own.

Supply of RCDP

We negotiate and manage a range of contracts for Australia's supply of blood and blood products and services. Learn more about suppliers and commercial supply contracts.

We have re-established supply arrangements to provide RCDP to Approved Recipients (which includes public sector laboratories and blood banking laboratories) from 1 July 2025. Approved Recipients as at 30 June 2025 will be able to continue purchasing Red Cell Diagnostic Products from 1 July 2025 subject to endorsement by the respective state and territory departments of health.

These arrangements will remain in place at least until 30 June 2028.

The Australian, state and territory governments jointly fund RCDP purchases made under these standing offer arrangements. From 1 July 2025, supply of these products is no longer subject to a funding cap or separate payment of delivery costs.

Buying RCDP or reporting product issues

We have standing offer contracts with the following companies until at least 30 June 2028.

You can see available products and how much they cost from each supplier in the RCDP price list. You can contact the suppliers to place an order for RCDP or report an issue with a product.

  • Red Cell Diagnostic Product Price List - 2025-28.XLSX
    35.29 KB

Bio-Rad Laboratories Pty Ltd

Phone: 1800 224 354
Fax: +61 2 9914 2888
Email: orders_australia@bio-rad.com

Grifols Australia Pty Ltd

Phone: 1800 339 479
Fax: +61 3 9535 9300
Email: australia_orders@grifols.com

Ortho-Clinical Diagnostics Australia Pty Ltd (Johnson & Johnson Medical Pty Ltd)

QuidelOrtho (Ortho-Clinical Diagnostics Australia Pty Ltd)
Phone: 1800 032 359
Email: ordersanz@quidelortho.com

Immulab Pty Ltd

Phone: 1300 369 559
Fax: +61 3 8833 7890
Email: immulaborders@paragoncare.com.au

Get in touch

Public pathology laboratories should first direct queries to their state or territory department of health.

To give direct feedback about any of our blood product suppliers, email supply.management.plasma@blood.gov.au.

Last updated: 01 Jul 2024

Back to top

The National Blood Authority acknowledges the Traditional Owners and Custodians of Country throughout Australia, and their continuing connection to land, water and community. We pay our respects to the people, the cultures and the elders past, present and emerging.

National Blood Authority

  • About the NBA
  • Work with us
  • Contact Us
  • Data and reporting
  • Freedom of information
  • Public interest disclosure
  • Resources
  • Accessibility
  • Privacy
  • Copyright
  • Disclaimer
  • BloodPortal Terms and Conditions of Use

Information

  • Blood Products
  • Managing blood supply
  • Supply systems
  • Clinical guidance
  • Patient information
  • Data and research
  • Website feedback